Form 4: Metagenomi Director Buys Shares
Insider Transaction (Form 4)
Laurence Reid, a Director of Metagenomi, Inc., purchased 20,000 shares of common stock on September 9, 2026.
Summary
- Open-market purchase: acquired 19,883 Common Stock at $1.17 ($23,263) on September 9, 2026; holds 19,883 after (Direct).
- Open-market purchase: acquired 117 Common Stock at $1.18 ($138) on September 9, 2026; holds 20,000 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $23,401, committing personal capital to the stock.
Insider Transactions
Laurence Reid — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-09 | Open-market purchase | Common Stock | 19,883 | $1 | $23.3K | 19,883 |
| 2026-09-09 | Open-market purchase | Common Stock | 117 | $1 | $138 | 20,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-09 | Open-market purchase (19,883 shares) |
| 2026-09-09 | Open-market purchase (117 shares) |
Keywords
insider transaction, Form 4, MGX, Metagenomi Therapeutics, Inc., bullish, Laurence Reid
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.